The Resource Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Resource Information
The item Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017 represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Indiana State Library.This item is available to borrow from 1 library branch.
Resource Information
The item Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017 represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Indiana State Library.
This item is available to borrow from 1 library branch.
- Language
- eng
- Extent
- 1 online resource (iii, 54 pages)
- Note
-
- "Serial no. 115-33."
- Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office
- Label
- Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Title
- Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain
- Title remainder
- hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Subject
-
- Generic drugs -- Development -- United States
- Generic drugs -- Development -- United States
- Pharmaceutical industry -- Corrupt practices -- United States
- Pharmaceutical industry -- Corrupt practices -- United States
- Competition -- United States
- Pharmaceutical policy -- United States
- Prescription pricing -- United States
- Prescription pricing -- United States
- Pharmaceutical policy -- United States
- Competition -- United States
- Consumer protection -- United States
- Consumer protection -- United States
- Language
- eng
- Cataloging source
- GPO
- Government publication
- federal national government publication
- Index
- no index present
- Literary form
- non fiction
- Nature of contents
-
- dictionaries
- bibliography
- http://bibfra.me/vocab/lite/organizationName
- United States
- http://library.link/vocab/subjectName
-
- Pharmaceutical industry
- Pharmaceutical policy
- Generic drugs
- Prescription pricing
- Competition
- Consumer protection
- Target audience
- general
- Label
- Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Note
-
- "Serial no. 115-33."
- Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office
- Bibliography note
- Includes bibliographical references
- Carrier category
- online resource
- Carrier category code
- cr
- Carrier MARC source
- rdacarrier
- Color
- black and white
- Content category
- text
- Content type code
- txt
- Content type MARC source
- rdacontent
- Control code
- 21275829
- Dimensions
- unknown
- Extent
- 1 online resource (iii, 54 pages)
- Form of item
- online
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
- c
- Specific material designation
- remote
- System control number
- (OCoLC)1013542208
- Label
- Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Note
-
- "Serial no. 115-33."
- Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office
- Bibliography note
- Includes bibliographical references
- Carrier category
- online resource
- Carrier category code
- cr
- Carrier MARC source
- rdacarrier
- Color
- black and white
- Content category
- text
- Content type code
- txt
- Content type MARC source
- rdacontent
- Control code
- 21275829
- Dimensions
- unknown
- Extent
- 1 online resource (iii, 54 pages)
- Form of item
- online
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
- c
- Specific material designation
- remote
- System control number
- (OCoLC)1013542208
Subject
- Generic drugs -- Development -- United States
- Generic drugs -- Development -- United States
- Pharmaceutical industry -- Corrupt practices -- United States
- Pharmaceutical industry -- Corrupt practices -- United States
- Competition -- United States
- Pharmaceutical policy -- United States
- Prescription pricing -- United States
- Prescription pricing -- United States
- Pharmaceutical policy -- United States
- Competition -- United States
- Consumer protection -- United States
- Consumer protection -- United States
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.in.gov/portal/Examining-the-impact-of-voluntary-restricted/AZZ5USHsXB8/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.in.gov/portal/Examining-the-impact-of-voluntary-restricted/AZZ5USHsXB8/">Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.in.gov/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.in.gov/">Indiana State Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.in.gov/portal/Examining-the-impact-of-voluntary-restricted/AZZ5USHsXB8/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.in.gov/portal/Examining-the-impact-of-voluntary-restricted/AZZ5USHsXB8/">Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.in.gov/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.in.gov/">Indiana State Library</a></span></span></span></span></div>
